BOLD-100 Plus Doxorubicin in Advanced Soft Tissue Sarcomas
Clinical trial NCT07027423 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07027423
- Sponsor
- University Health Network, Toronto
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-30
- Primary completion
- 2027-01-29
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.